Researchers determined the clinical classification of more than 90% of potential BRCA2 variants of uncertain significance in ...

AstraZeneca announced that its drug Lynparza (olaparib) has been approved for use in Scotland. The approval by the Scottish ...

Sarah Anderson, oncology strategy lead director, Novotech, discusses the significance of triple-negative breast cancer research in the Asia-Pacific region, and the importance of clinical trial ...

Genetics is key to the development of cancer and also in the progression. Some inherited mutations confer a susceptibility to ...

Genetics significantly impact cancer risk, particularly in inherited mutations like BRCA1/BRCA2, which increase ...

Susan M. Domchek, MD, FASCOPHILADELPHIA - Susan M. Domchek, MD, FASCO, has been recognized by the American Society of Clinical Oncology (ASCO) with ...

Spatially resolved protein profiling in pancreatic adenosquamous carcinoma. Age, number of genomic alterations (GA) per tumor, and alteration frequency of select commonly altered genes based on TP53 ...

Analysis of tumor microenvironmental features of primary and synchronous liver metastases from patients with colorectal cancer using a deep learning algorithm. Real-world analysis of the impact of ...

The company, which secured $200 million from investors in a private funding deal last week, learned Tuesday of a serious side effect experienced by one participant on a high dose of its Rett therapy.

Purpose: The incidence of lung cancer is closely associated with diabetes; however, it remains unclear whether diabetes influences the genetic mutations present in lung cancer. Therefore, we will ...

Mutations of other genes can increase the risk of getting Alzheimer’s but do not necessarily cause it. Only a few rare gene mutations are known to cause Alzheimer’s – and the GRIN2C mutation ...